Corrigendum to "Characterization of an immunodeficient mouse model of mucopolysaccharidosis type I suitable for preclinical testing of human stem cell and gene therapy" [Brain. Res. Bull 74 (2007) 429-438] (DOI:10.1016/j.brainresbull.2007.07.018);Characterization of an immunodeficient mouse model of mucopolysaccharidosis type I suitable for preclinical testing of human stem cell and gene therapy

Brain Research Bulletin

Volumn 74, Issue 6, 2007, Pages 429-438

  Garcia Rivera, Mayra F ^b   Colvin Wanshura, Leah E ^a   Nelson, Matthew S ^a   Nan, Zhenhong ^b   Khan, Shaukat A ^a   Rogers, Tyson B ^c   Maitra, Indrani ^b   Low, Walter C ^b   Gupta, Pankaj ^a,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Animal model; Ganglioside; Glycosaminoglycans; Iduronidase; Mice; Mucopolysaccharidosis I; Rotarod performance test; Stem cell

Indexed keywords

ALPHA LEVO IDURONIDASE; GAG PROTEIN; GANGLIOSIDE GM3; LEVO IDURONIDASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; BIOCHEMISTRY; BIOSTATISTICS; BRAIN; BRAIN DYSFUNCTION; BRAIN LEVEL; BRAIN STEM; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME ACTIVITY; EXPERIMENTAL MODEL; FEMALE; GENE THERAPY; GENOTYPE; HEART; HETEROZYGOTE; HURLER SYNDROME; IMMUNE DEFICIENCY; IMMUNE RESPONSE; KIDNEY; LEARNING; LIVER; LUNG; MALE; MOTOR COORDINATION; MOTOR CORTEX; MOTOR PERFORMANCE; MOUSE; NEUROPATHOLOGY; NEUROTRANSMISSION; NONHUMAN; NONOBESE DIABETIC MOUSE; PHENOTYPE; PRIORITY JOURNAL; PROPRIOCEPTION; PROTEIN LOCALIZATION; RELIABILITY; REPRODUCIBILITY; ROTAROD TEST; ROTATION; SCID MOUSE; SENSORIMOTOR FUNCTION; SEX DIFFERENCE; SKELETON MALFORMATION; SPLEEN; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME; URINARY EXCRETION;

EID: 34848831191     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2008.05.002     Document Type: Erratum

References (38)

1. Bhatia M., Bonnett D., Murdoch B., Gan O.I., and Dick J.E. A newly discovered class of human hematopoietic cells with SCID-repopulating activity. Nat. Med. 4 (1998) 1038-1045
2. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
3. Braunlin E., Mackey-Bojack S., Panoskaltsis-Mortari A., Berry J.M., McElmurry R.T., Riddle M., Sun L.Y., Clarke L.A., Tolar J., and Blazar B.R. Cardiac functional and histopathologic findings in humans and mice with mucopolysaccharidosis type I: implications for assessment of therapeutic interventions in hurler syndrome. Pediatr. Res. 59 (2006) 27-32
4. Chandrasekhar S., Esterman M.A., and Hoffman H.A. Microdetermination of proteoglycans and glycosaminglycans in the presence of guanidine hydrochloride. Anal. Biochem. 161 (1987) 103-108
5. Clarke L.A., Russell C.S., Pownall S., Warrington C.L., Borowski A., Dimmick J.E., Toone J., and Jirik F.R. Murine mucopolysaccharidosis type I: targeted disruption of the murine alpha-l-iduronidase gene. Hum. Mol. Genet. 6 (1997) 503-511
6. Di Domenico C., Villani G.R., Di Napoli D., Reyero E.G., Lombardo A., Naldini L., and Di Natale P. Gene Therapy for a mucopolysaccharidosis type I murine model with lentiviral-IDUA vector. Hum. Gene Ther. 16 (2005) 81-90
7. Dick J.E., Bhatia M., Gan O.I., Kapp U., and Wang J.C. Assay of human stem cells by repopulation of NOD/SCID mice. Stem Cells 15 (1997) 199-203
8. Dick J.E., Guenechea G., Gan O.I., and Dorrell C. In vivo dynamics of human stem cell repopulation in NOD/SCID mice. Ann. N. Y. Acad. Sci. 938 (2001) 184-190
9. Fujimoto S.T., Longhi L., Saatman K.E., Conte V., Stocchetti N., and McIntosh T.K. Motor and cognitive function evaluation following experimental traumatic brain injury. Neurosci. Biobehav. Rev. 28 (2004) 365-378
10. Glaros E.N., Turner C.T., Parkinson E.J., Hopwood J.J., and Brooks D.A. Immune response to enzyme replacement therapy: single epitope control of antigen distribution from circulation. Mol. Genet. Metab. 77 (2002) 127-135
11. Graupman P., Pan D., Konair B., Hartung S., McIvor S., Whitley C., Low W., and Lam C.H. Craniofacial abnormalities in a murine knock-out model of mucopolysaccharidosis I H: a computed tomography and anatomic study. J. Craniofac. Surg. 15 (2004) 392-398
12. Hartung S.D., Frandsen J.L., Pan D., Koniar B.L., Graupman P., Gunther R., Low W.C., Whitley C.B., and McIvor R.S. Correction of metabolic, craniofacial, and neurologic abnormalities in MPS I mice treated at birth with adeno-associated virus vector transducing the human alpha-l-iduronidase gene. Mol. Ther. 9 (2004) 866-875
13. Haskins M.E., Aguirre G.D., Jezyk P.F., Desnick R.J., and Patterson D.F. The pathology of the feline model of mucopolysaccharidosis I. Am. J. Pathol. 112 (1983) 27-36
14. Haskins M.E., Jezyk P.F., Desnick R.J., McDonough S.K., and Patterson D.F. Alpha-L-iduronidase deficiency in a cat: a model of mucopolysaccharidosis I. Pediatr. Res. 13 (1979) 1294-1297
15. Hogan C.J., Shpall E.J., McNulty O., McNiece I., Dick J.E., Shultz L.D., and Keller G. Engraftment and development of human CD34+ enriched cells from umbilicl cord blood in NOD/LtSz-scid/scid mice. Blood 90 (1997) 85-96
16. Jordan M.C., Zheng Y., Ryazantsev S., Rozengurt N., Roos K.P., and Neufeld E.F. Cardiac manifestations in the mouse model of mucopolysaccharidosis I. Mol. Genet. Metab. 86 (2005) 233-243
17. Kakkis E.D., Schuchman E., He X., Wan Q., Kania S., Wiemelt S., Hasson C.W., O'Malley T., Weil M.A., Aguirre G.A., Brown D.E., and Haskins M.E. Enzyme replacement therapy in feline mucopolysaccharidosis I. Mol. Genet. Metab. 72 (2001) 199-208
18. Li Y., Chen J., Wang L., Zhang L., Lu M., and Chopp M. Intracerebral transplantation of bone marrow stromal cells in a 1- methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. Neurosci. Lett. 316 (2001) 67-70
19. Liu Y., Xu L., Hennig A.K., Kovacs A., Fu A., Chung S., Lee D., Wang B., Herati R.S., Ogilvie J.M., Cai S.R., and Ponder K.P. Liver-directed neonatal gene therapy prevents cardiac, bone, ear, and eye disease in mucopolysaccharidosis I mice. Mol. Ther. 11 (2005) 35-47
20. Lutzko C., Kruth S., Abrams-Ogg A.C., Lau K., Li L., Clark B.R., Ruedy C., Nanji S., Foster R., Kohn D., Shull R., and Dube I.D. Genetically corrected autologous stem cells engraft, but host immune responses limit their utility in canine alpha-L-iduronidase deficiency. Blood 93 (1999) 1895-1905
21. Lyon G., Adams R.D., and Kolodny E.H. Late infantile Progressive Genetic Encephalopathies. Neurology of Hereditary Metabolic Diseases of Children (1996), McGraw Hill, New York pp. 124-176
22. Ma X., Liu Y., Tittiger M., Hennig A., Kovacs A., Popelka S., Wang B., Herati R., Bigg M., and Ponder K.P. Improvements in mucopolysaccharidosis I mice after adult retroviral vector-mediated gene therapy with immunomodulation. Mol. Ther. 15 (2007) 889-902
23. McKenzie J.L., Gan O.I., Doedens M., and Dick J.E. Human short-term repopulating stem cells are efficiently detected following intrafemoral transplant into NOD/SCID recipients depleted of CD122+ cells. Blood 106 (2005) 1259-1261
24. Meertens L., Zhao Y., Rosic-Kablar S., Li L., Chan K., Dobson H., Gartley C., Lutzko C., Hopwood J.J., Kohn D.B., Kruth S., Hough M.R., and Dube I.D. In utero injection of alpha-L-iduronidase carrying retrovirus in canine mucopolysaccharidosis type I: infection of multiple tissues and neonatal gene expression. Hum. Gene Ther. 13 (2002) 1809-1820
25. Neufeld E.F., and Muenzer J. The mucopolysaccharidoses. In: Scriver C.R., Beaudet A.L., Sly W.S., Valle D., Childs B., Kinzler K.W., and Vogelstein B. (Eds). The Metabolic and Molecular Basis of Inherited Disease vol. III (2001), McGraw-Hill, New York, NY 3421-3452
26. Nonoyama S., Smith F.O., Bernstein I.D., and Ochs H.D. Strain-dependent leakiness of mice with severe combined immune deficiency. J. Immunol. 150 (1993) 3817-3824
27. Ohmi K., Greenberg D.S., Rajavel K.S., Ryazantsev S., Li H.H., and Neufeld E.F. Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 1902-1907
28. Reolon G.K., Braga L.M., Camassola M., Luft T., Henriques J.A., Nardi N.B., and Roesler R. Long-term memory for aversive training is impaired in Idua(-/-) mice, a genetic model of mucopolysaccharidosis type I. Brain Res. 1076 (2006) 225-230
29. Russell C., Hendson G., Jevon G., Matlock T., Yu J., Aklujkar M., Ng K.Y., and Clarke L.A. Murine MPS I: insights into the pathogenesis of Hurler syndrome. Clin. Genet. 53 (1998) 349-361
30. Schuchman E.H., Guzman N.A., and Desnick R.J. Human alpha-L-iduronidase. I. Purification and properties of the high uptake (higher molecular weight) and the low uptake (processed) forms. J. Biol. Chem. 259 (1984) 3132-3140
31. Shull R.M., Helman R.G., Spellacy E., Constantopoulos G., Munger R.J., and Neufeld E.F. Morphologic and biochemical studies of canine mucopolysaccharidosis I. Am. J. Pathol. 114 (1984) 487-495
32. Shull R., Lu X., Dube I., Lutzko C., Kruth S., Abrams-Ogg A., Kiem H.P., Goehle S., Schuening F., Millan C., and Carter R. Humoral immune response limits gene therapy in canine MPS I. Blood 88 (1996) 377-379
33. Shull R.M., Munger R.J., Spellacy E., Hall C.W., Constantopoulos G., and Neufeld E.F. Canine alpha-L-iduronidase deficiency. A model of mucopolysaccharidosis I. Am. J. Pathol. 109 (1982) 244-248
34. Shultz L.D., Schweitzer P.A., Christianson S.W., Gott B., Schweitzer I.B., Tennent B., McKenna S., Mobraaten L., Rajan T.V., Greiner D.L., and Leiter E.H. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J. Immunol. 154 (1995) 180-191
35. Spellacy E., Shull R.M., Constantopoulos G., and Neufeld E.F. A canine model of human alpha-L-iduronidase deficiency. Proc. Natl. Acad. Sci. U.S.A. 80 (1983) 6091-6095
36. Wang J.C., Lapidot T., Cashman J.D., Doedens M., Addy L., Sutherland D.R., Nayar R., Laraya P., Minden M., Keating A., Eaves A.C., Eaves C.J., and Dick J.E. High level engraftment of NOD/SCID mice by primitive normal and leukemic hematopoietic cells from patients with chronic myeloid leukemia in chronic phase. Blood 91 (1998) 2406-2414
37. Whitley C.B. The mucopolysaccharidoses. In: Moser H.W. (Ed). Neurodystrophies and Neurolipidoses vol. 66 (22) (1996), Elsevier Science 281-328
38. Zheng Y., Rozengurt N., Ryazantsev S., Kohn D.B., Satake N., and Neufeld E.F. Treatment of the mouse model of mucopolysaccharidosis I with retrovirally transduced bone marrow. Mol. Genet. Metab. 79 (2003) 233-244